Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"Ranolazine"”.
-
Ranolazine: a Potential Anti-diabetic Drug
… to treat diabetes [1]. In my study, I tested if ranolazine, a synthetic compound, has potential to prevent or treat diabetes. Diabetes were induced in mice by giving multiple low-doses of streptozotocin (STZ). Ranolazine was given twice daily via an oral gavage (20 mg/kg) for 5 weeks. blood …
-
Συνδυασμός ρανολαζίνης - αμιωδαρόνης έναντι αμιωδαρόνης στο χρόνο ανάταξης της πρωτοεμφανισθείσας (new-onset) ή παροξυσμικής κολπικής μαρμαρυγής και εκτίμηση λειτουργικής συμπεριφοράς του αριστερού κόλπου
… chosen a combination therapy of amiodarone with ranolazine, a new antianginal agent, with strong atrial-selective inhibitory effect of Late Na+ channel, with a view to evaluate the conversion time and the conversion rate of AF. We have also planned to compare the function of the left atrium for …
-
Η συγχορήγηση της ρανολαζίνης στην ταχύτητα ανάταξης της μετεγχειρητικής κολπικής μαρμαρυγής με αμιωδαρόνη σε ασθενείς μετά από αορτοστεφανιαία παράκαμψη
… we chose to co-administer amiodarone with ranolazine, a new antianginal agent with a stronger atrial-selective Na+ blocking activity, to study the time and rates of postoperative atrial fibrillation conversion within 36 hours of onset of intravenous infusion.In a single-center, prospective, …
-
Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
… simulations under the pharmacologic effects of ranolazine.</p> <p>HCM cardiomyocytes had enhanced sensitivity to ischaemia, where the presence of ionic remodelling increased arrhythmic risk in ischaemic simulations, particularly for transmural insults. This enhanced ischaemic cellular response …
-
Calcium and Redox Control of the Calcium Release Mechanism of Skeletal and Cardiac Muscle Sarcoplasmic Reticulum
… the solution redox status became more oxidative. Ranolazine, a drug used for treating Angina Pectoris (chest pain), desensitized the cardiac CRC activation but had no effect on the skeletal CRC. This selective desensitization may be the cause of Ranolazine's beneficial therapeutic effects. Both …
-
Molecular Studies of Alpha-Scorpion Toxin Interactions with Voltage-gated Sodium Channels
… that an antianginal and anti-ischemic drug, ranolazine, attenuated sustained Na+ current induced by alpha-scorpion toxin, with a 50% inhibitory concentration (IC50) of 102 ± 10.7 uM. It also attenuated the peak Na+ currents, with an IC50 of 334 ± 2.6 uM. The results demonstrate that …
-
Studies on the Metabolic and Functional Consequences of Ischaemia in the Mammalian Myocardium
… The effects of the novel anti-ischaemic agent, ranolazine (Syntex), were investigated in the low-flow ischaemia model. Ranolazine preserved the myocardial ATP content and reduced lactate and creatine kinase release during the ischaemic period. These protective effects were associated with an …
-
Molecular Basis of Class Ib Drug Interactions with the NaV Channel Macromolecular Complex: A Route to Personalized Medicine for Cardiac Arrhythmia
… Class Ib antiarrhythmics, such as lidocaine, ranolazine and mexiletine. Recent clinical studies showed that mexiletine is effective in treating patients with LQT3 syndrome. However, the patient response is variable, depending on the genetic mutation in NaV 1.5. We showed that mexiletine …
-
Characterising mechanisms to stratify therapy in patients with angina and nonobstructive coronary arteries
… to anti-ischaemic therapy (amlodipine and ranolazine) in patients with ANOCA. The primary outcome was the difference in change in exercise time in response to anti-ischaemic therapy between those with an impaired CFR (coronary microvascular disease group; CMD) and those with a normal CFR …
-
Acute Sodium Flux as a Driver of Morphological and Motility Instability in MDA-MB-231 and MCF-7 Breast Cancer Cells
… Nav1.5-deficient MCF-7 cells. The VGSC inhibitor ranolazine in MDA-MB-231 cells produced minimal effects over the short-term windows tested (5 min to 24 h), consistent with low basal persistent sodium current under normoxia. In contrast, sustaining VGSC activity with aconitine triggered rapid …
-
Biowire II Platform: High Fidelity Heart-on-a-chip for Drug Screening and Disease Modeling
… spatially confined responses to serotonin and ranolazine. More importantly, Biowire II platform enabled modeling of polygenic left ventricular hypertrophy with induced pluripotent stem cell derived cardiomyocytes from six different patients, using uniquely designed 8-months-long electrical …
-
Targeting Voltage Gated Sodium Channels for Prevention of Breast Cancer Metastasis
… than the known clinically used VGSC blockers (ranolazine and phenytoin) with non-cancer indications.
-
Persistent and transient Na⁺ currents in hippocampal CA1 pyramidal neurons
The biophysical properties and distribution of voltage gated ion channels shape the spatio-temporal pattern of synaptic inputs and determine the input-output properties of the neuron. Of the various voltage-gated ion channels, persistent Na⁺ current (INaP) is of interest because of its activation …